| Immunogenicity, efficacy and safety of Nuwiq® (human‐cl rhFVIII) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect … RJ Liesner, M Abashidze, O Aleinikova, C Altisent, MJ Belletrutti, ... Haemophilia 24 (2), 211-220, 2018 | 36 | 2018 |
| Simoctocog alfa (Nuwiq) in previously untreated patients with severe haemophilia A: final results of the NuProtect study RJ Liesner, A Abraham, C Altisent, MJ Belletrutti, M Carcao, M Carvalho, ... Thrombosis and Haemostasis 121 (11), 1400-1408, 2021 | 28 | 2021 |
| COVID-19-induced coagulopathy: Experience, achievements, prospects L Dubey, O Dorosh, N Dubey, S Doan, O Kozishkurt, O Duzenko, ... Cardiology Journal 30 (3), 453-461, 2023 | 14 | 2023 |
| Test-retest reliability of Ukrainian version of the Haemo-QoL questionnaire A Markin, L Dubey EUREKA: Health Sciences, 21-29, 2018 | 7 | 2018 |
| Unfriendly fire: how the tobacco industry is destroying the future of our children A Bush, T Ferkol, A Valiulis, A Mazur, I Chkhaidze, T Maglakelidze, ... Acta Medica Lituanica 28 (1), 6, 2021 | 6 | 2021 |
| Health-related quality of life in children with hemophilia А: international experience and national realities AI Markin, D LYa, K KhM, NV Dubey Perinatology and pediatric. Ukraine 4 (72), 125-34, 2017 | 5 | 2017 |
| The pathogenesis of COVID-19: Hypercoagulation and D-dimer in thrombotic complications FS EDIZIONI J Health Soc Sci 8 (1), 45-58, 2023 | 4 | 2023 |
| Inhibitor Development in Previously Untreated Patients with Severe Hemophilia a Treated with Nuwiq®, a New Generation Recombinant FVIII of Human Origin R Liesner, M Abashidze, O Aleinikova, C Altisent, MJ Belletrutti, ... Blood 128 (22), 327, 2016 | 4 | 2016 |
| Histiocytosis from Langerhans cells: features of clinical and laboratory manifestations and the course of the disease OI Dorosh, IP Tsymbalyuk-Voloshin, RS Polishchuk, LY Dubei, OI Vorobel, ... Zdorov’e rebenka 5 (56), 40-50, 2014 | 3 | 2014 |
| Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A—Final efficacy and safety results from the NuProtect study M Mathias, A Abraham, MJ Belletrutti, M Carcao, M Carvalho, ... European Journal of Haematology 111 (4), 544-552, 2023 | 1 | 2023 |
| Long‐term immunogenicity, efficacy and tolerability of simoctocog alfa in patients with severe haemophilia A who had completed the NuProtect study in previously untreated patients M Mathias, M Abashidze, A Abraham, MJ Belletrutti, M Carcao, ... Haemophilia 29 (4), 1005-1012, 2023 | 1 | 2023 |
| Health-Related Quality of Life in Children with Severe Hemophilia A in Ukraine: Age-Related Features on the Influence of the Substitution Treatment Methods AI Markin, LY Dubey Web of Scholar 2 (7), 15-19, 2018 | 1 | 2018 |
| Синдром Дауна у практиці гематолога ОІ Дорош, ОО Трояновська, ОІ Очеретна, НІ Кіцера, АЛ Іваненко, ... Современная педиатрия, 130-146, 2017 | 1 | 2017 |
| Якість життя дітей з гемофілією а, пов’язана зі здоров’ям: міжнародний досвід та вітчизняні реалії AI Markin, LY Dubey, KM Komendant, NV Dubey Перинатология и педиатрия, 125-134, 2017 | 1 | 2017 |
| Набута апластична анемія: особливості клініко-лабораторних проявів та перебігу хвороби, аналіз лікування ОІ Дорош, ІП Цимбалюк—Волошин, РС Поліщук, ОІ Воробель, ... Современная педиатрия, 33-42, 2016 | 1 | 2016 |
| von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease RF Sidonio Jr, A Boban, L Dubey, A Inati, C Kiss, Z Boda, T Lissitchkov, ... Blood Advances 8 (6), 1405-1414, 2024 | | 2024 |
| Складність діагностики рефрактерної хвороби Кавасакі під «маскою» гемобластозу: клінічний випадок із досвіду гематолога OI Dorosh, MR Sheremet, VP Yevtukh, OM Ocheretna, LY Dubey, ... Modern Pediatrics. Ukraine, 111-123, 2024 | | 2024 |
| Efficacy of Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Reducing Nose Bleeds in Children and Adults with Von Willebrand Disease A Boban, RF Sidonio Jr, L Dubey, KV Vilchevska, A Inati, CD Khayat Blood 142, 5509, 2023 | | 2023 |
| Efficacy and Safety of Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Children and Adolescents with Von Willebrand Disease-a Sub-Analysis of … RF Sidonio Jr, L Dubey, KV Vilchevska, A Inati, CD Khayat Blood 142, 3992, 2023 | | 2023 |
| Efficacy of Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate in Reducing Heavy Menstrual Bleeding in Females with Von Willebrand Disease C Kiss, Z Boda, CD Khayat, L Dubey, RF Sidonio Jr Blood 142, 3997, 2023 | | 2023 |
Nataliya DubeyPh. D., M.D.,Danylo Halytsky Lviv National Medical UniversityVerified email at meduniv.lviv.ua
